Personalized genetic testing helps reduce adverse events following balloon angioplasty
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
No hay comentarios:
Publicar un comentario